Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis-Reference-Cited by-同舟云学术

Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis

Published:2021-05-19 Issue:7 Volume:37 Page:1085-1097
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Alamer Ahmad¹²^ORCID,Alrashed Ahmed A.³,Alfaifi Mashael⁴,Alosaimi Bandar⁵^ORCID,AlHassar Fatimah⁶,Almutairi Malak⁷,Howaidi Jude³,Almutairi Wedad⁸,Mohzari Yahya⁴,Sulaiman Tarek⁹,Al-jedai Ahmed¹⁰¹¹^ORCID,Alajami Hamdan N.¹²,Alkharji Fatima³,Alsaeed Ali¹³,Alali Alaa H.¹⁴^ORCID,Baredhwan Abdullah A.¹⁴^ORCID,Abraham Ivo¹¹⁵^ORCID,Almulhim Abdulaziz S.¹⁶^ORCID

Affiliation:

1. Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA

2. Department of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia

3. Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia

4. Clinical Pharmacy Department, King Saud Medical City, Riyadh, Saudi Arabia

5. Research Center, King Fahad Medical City, Riyadh, Saudi Arabia

6. Department of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

7. Department of Pharmacy Practice, College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia

8. Department of Clinical Pharmacy, Shaqra University, Riyadh, Saudi Arabia

9. Department of Infectious Diseases, King Fahad Medical City, Riyadh, Saudi Arabia

10. Ministry of Health, Deputyship of Therapeutic Affairs, Riyadh, Saudi Arabia

11. Alfaisal University, Colleges of Pharmacy and Medicine, Riyadh, Saudi Arabia

12. Pharmaceutical Services Administration, King Saud Medical City, Riyadh, Saudi Arabia

13. Neurology Department, King Fahad Medical City, Riyadh, Saudi Arabia

14. Department of Infectious Diseases, King Saud Medical City, Riyadh, Saudi Arabia

15. Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA

16. Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1920900

Reference40 articles.

1. COVID-19, SARS and MERS: are they closely related?

2. Objective evaluation of anosmia and ageusia in COVID ‐19 patients: Single‐center experience on 72 cases

3. Olfactory and gustatory function impairment in COVID ‐19 patients: Italian objective multicenter‐study

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

5. The journey of remdesivir: from Ebola to COVID-19

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple inborn errors of type I IFN immunity in a 33-year-old male with a fatal case of COVID-19;Heliyon;2024-04

2. Assessment of the efficacy and safety of favipiravir in patients with SARS-CoV-2 infection in United Arab Emirates: A single-center study;PHARM PRACT-GRANADA;2024

3. Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19;Inflammopharmacology;2024-03-16

4. A solvent-free HPLC method for the simultaneous determination of Favipiravir and its hydrolytic degradation product;Scientific Reports;2023-10-28

5. When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study;Journal of Infection and Public Health;2023-09